Viewing Study NCT06229171



Ignite Creation Date: 2024-05-06 @ 8:01 PM
Last Modification Date: 2024-10-26 @ 3:19 PM
Study NCT ID: NCT06229171
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-01-29
First Post: 2024-01-19

Brief Title: InTake Care Development and Validation of an Innovative Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention
Sponsor: Istituto Auxologico Italiano
Organization: Istituto Auxologico Italiano

Study Overview

Official Title: InTake Care Development and Validation of an Innovative Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: InTakeCare
Brief Summary: Inadequate medication adherence MA in chronic conditions including cardiovascular prevention represents an important risk factor The use of new IT technologies in this setting is supposed to be useful to improve patients adherence but currently available solutions have significant limitations including lack of personalization and reliance on expensive ad hoc systems

This interdisciplinary project aims to verify the hypothesis that in patients on chronic antihypertensive treatment MA can be improved through the implementation of a novel digital health solution for MA monitoring and support based on inexpensive and user-friendly commercially available technology voice assistant connected with web interface for the physician The intervention will be personalized based on the creation of Personas intended as multidisciplinary-based representations of different user types This approach will be tested in a randomized clinical trial
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None